Reinventing The Medical Trial

Clinical trials actually progress ahead based on the initial drafted action plan called protocol. The medical trial protocols are usually designed to direct the clinical trial process to the destination. The point that comes for the discussion at this juncture is, what if the initial interpretations on designing the clinical trial protocol prove to be wrong? This is where the reinventing the medical trial comes into the picture. The actual design of the clinical trial protocol is designed based on the assumptions when the researcher had no clue about the uncertain circumstances in the clinical trial.

 

This protocol may convey long and lengthy process which in turn raises the cost of research and development in the medical trial. When the actual process is being carried on the researcher may get the new innovative ideas to the chunk the process into small blocks that can be completed in the  short period of time with much less investment when compared to the details drafted in the medical trial protocol. The process of re-framing the clinical trial protocol to reduce the investment of research and development and the time is called as reinventing the medical trial.

How Would The Typical Clinical Trial Process Run?

Clinical trial process is conducted to give the new treatment or the drug or the medical device to the open world. How would this typical medical process run, the question wondering in the brains of the outside world.

The participant will be asked to sign the informed consent by understanding the content of the informed consent. Any clarifications regarding that will be provided by the medical trial co-coordinator or the medical expert. Once the informed consent is signed, the volunteer participant would undergo the medical screening to make sure that he/she fits in the credentials of the clinical trial. If the patient passes the medical tests she/he will be given the medicine and will be asked to reach the location for the next scheduled treatment. The information regarding whether the participant is undergoing a placebo treatment will not be disclosed to the patient. In the clinical trials the patient can enjoy the facility of quitting the medical trial process at any point of time.

Why Should you Prefer Adaptive Design in Clinical Trials?

Clinical trial funding has become very expensive these days; the medical trials are not showing the effective results in spite of pouring money and extensive effort. The prolonged clinical trial process would be the standing pillar behind these impaired results of the clinical trial today. The traditional clinical trial infrastructure is nearing the breaking point and it needs to be modified says the experts. One of the feasible solutions to cut down the increasing cost and reduce the time lag of the medical trials is to choose adaptive design in the clinical trial. 

To come out with an adaptive clinical trial design, it needs a modification in several aspects like staff training, trial oversight, regulatory communication and data capture, including ethics, finances, regulatory control, methodology, logistics, statistics and technology. Properly executed clinical trials gathers the efforts from everybody and gives you the valid outcomes in the shortest time and less cost.

Problems With The Placebo Clinical Trials

Clinical trials are always conducted to measure the performance of the medicine by comparing the results of between the two sets of people. The set who does not receive the experimental treatment are said to receive the placebo treatment. The problem at this juncture is these placebo treatments are being faked by the pharmaceutical companies. The medicine given in the placebo treatment is supposed to be inert but, they are not. The pills given the placebo are given to raise the betterment the experimental drug.  

How does this happen? If the clinical trial is being conducted to measure the performance of the pill the improves the health of the heart. The placebo treatment will be given a pill the spoils the health of the heart and there results show high performance of the experimental drug. The ingredients of the placebo treatment should be detailed to avoid any such circumstances. Then your clinical research will be intended on giving a best medicine or treatment to the outside world rather than pushing the experimented drug into the market with no results.

Clinical Trials Are Now Growing Global

Clinical trial phase of medical research are gaining wide exposure these days. The shortage of treatment naive and the trial participants is increasing the time period of the clinical trials drastically which in turn is affecting the cost factor. 

The recent article from the Reuters, Clinical Trials.gov states that there are roughly 106,000 human clinical trials that are underway around the world out of which 50 percent takes place in US only. Just imagine the demand for the trial participants in the US. The scarcities of the trial participants in the medical trials stretch its hands globally. In the recent times most of the participants of the clinical trial come from the developing countries and the initial two stages of the clinical trial Phase I and Phase II are conducted in the foreign countries and third stage Phase III is again brought to US. The problem with the clinical trials is adherence of the ethics like the affordability the expensive medication in the foreign countries, and getting the participants educated about the informed consent. If these ethics are strictly adhered, the clinical trial proves to be very affordable with its increasing scope.

Clinical Trial Plays A Key Role In The Medical Excellence Today

The early generations were treating the health issues with the natural remedies. The gradual rise in the pollution of the nature and changing life style brought many uncured into the picture. In the early 1900 vaccines treated the uncured diseases, antibiotics came in 1940s and the emergence of biotechnology happened in early 1980s. The medical world in the 21^st century is much advanced than this. Both the effects of pollution and the medicine grew in parallel to each other.  The medical world is equipped with number of medicines to hit the challenges of the nature. 

How did the world come to know about the right medicine to treat the particular health issue? Clinical trials are the main drivers behind the excellence of the medical field today. The results of the clinical trial assured the better treatment and the medication for the many uncured diseases in the early days. 

Clinical trials are conducted on the group of people who gives their consent for the volunteer participation. Investigational study is conducted by experimenting the medicine on the group of people to ensure that the stated result of the drug proves to be effective. The drug undergoes years of research and has to get many approvals from the medical authorities to reach the clinical trial stage after which it undergoes a thorough analysis and get many approvals to enter the market.

What is Clinical Trial protocol?

Most of them have the doubts about what the clinical trial protocol is. It is nothing but the document filled with the contents about the trial design to obtain the conformation from the panel of experts in spite of being conducted in different countries. What does it contain?

Clinical trial protocol describes the scientific rationale, objective(s), design, methodology, statistical considerations, and organization of the planned trial. The investigator brochure of the clinical protocol adds all the supporting documents for the details mentioned in the clinical trial protocol. The detailed study plan in the protocol assures the safety of the participants besides providing investigators a template for the trial. It also details the list of administrators, researchers and other team responsible for handling the clinical trial. The format of the clinical trial protocol sponsored by pharmaceutical, biotechnology or medical device companies.